Gonzalez-Lluch, C.; Basagaña, M.; Pardo, L.; Cruz Toro, P.; Hernandez-Biette, A.; Martinez-Rivera, C.; Garcia-Olive, I.
Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab. J. Pers. Med. 2025, 15, 471.
https://doi.org/10.3390/jpm15100471
AMA Style
Gonzalez-Lluch C, Basagaña M, Pardo L, Cruz Toro P, Hernandez-Biette A, Martinez-Rivera C, Garcia-Olive I.
Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab. Journal of Personalized Medicine. 2025; 15(10):471.
https://doi.org/10.3390/jpm15100471
Chicago/Turabian Style
Gonzalez-Lluch, Carlota, Maria Basagaña, Laura Pardo, Paula Cruz Toro, Agnes Hernandez-Biette, Carlos Martinez-Rivera, and Ignasi Garcia-Olive.
2025. "Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab" Journal of Personalized Medicine 15, no. 10: 471.
https://doi.org/10.3390/jpm15100471
APA Style
Gonzalez-Lluch, C., Basagaña, M., Pardo, L., Cruz Toro, P., Hernandez-Biette, A., Martinez-Rivera, C., & Garcia-Olive, I.
(2025). Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab. Journal of Personalized Medicine, 15(10), 471.
https://doi.org/10.3390/jpm15100471
